ADC Therapeutics Q1 2026 Earnings EPS Beat but No Revenue Reported Stock Slips RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32 ORN Q1 2026 Earnings EPS Surprises Positively Revenue Uncertainty Weighs on Shares AES Q1 2026 Earnings EPS Surges 80 Above Estimates Powered by Strong Execution Texas Capital Bancshares Series B TCBIO Q1 2026 Earnings EPS Exceeds Estimates as Preferred Stock Holds Steady EXPE Q1 2026 Earnings EPS Surges Past Estimates Stock Jumps 39